Authors



Royce Burruss, RPh, MBA, FASCP

Latest:

The Changing Clinical Assessment: An Overview and Next-Level Challenges

The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.




Mischa Pesicek, PharmD

Latest:

Walmart Essay Winner: A Community Pharmacist's Impact Can Go a Long Way

"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."






Benjamin Chastek, MS

Latest:

Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients

Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.


Stephanie Watson, PharmD Candidate

Latest:

Unanticipated Learning Opportunities for Pharmacy Students During COVID-19

The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.


Joanne LaFleur, PharmD, MSPH

Latest:

Biopharmaceuticals: A Way Forward for Biogenerics?

Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.


By Aimee Simone, Pharmacy Times Assistant Editor

Latest:

Specialty Pharmacies May Improve Care for Hemophilia, vWD Patients

To improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.


Huabin F. Zhang, MD, MPH

Latest:

Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic Therapies

Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.



David Schaaf, MD

Latest:

Understanding Predictors of Opioid Abuse: Predictive Model Development and Validation

This study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.


Aimee Simone, Associate Editor

Latest:

New on the Job: Dos and Don'ts

These tips can help recent pharmacy school graduates navigate the professional world.



Christopher D. Altman, PharmD

Latest:

HPV Update: Making Sense of the New ACIP Recommendations

Previously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.



Trista Pfeiffenberger, PharmD, MS

Latest:

Medication Management: A Team Sport

How do we achieve optimal results for patients? This vision includes strategies and steps for a broader system of care based on the premise that health care professionals cannot go it alone.


Gabrielle Ruggiero, 2016 PharmD Candidate

Latest:

3 Findings on Colds You May Have Missed

Three studies published last year provide useful information on risk factors for colds, which affect adults 2 to 3 times a year.



Lauren McKnight, PharmD, CPP, BCACP

Latest:

Neuropathic Pain

Neuropathic pain is a chronic nerve pain that can significantly impair a patient's functioning and quality of life.


Kathleen O'Dell, CPhT

Latest:

A Call to Action for Evidence-based, Outcomes-driven Conflict Management Styles

With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.


Anissa Cyhaniuk, MA

Latest:

Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease

This study evaluated the rates of dose escalation in patients with Crohn's disease.


Ellane Guiao, PharmD Candidate

Latest:

Clinical Insights: Palforzia is the First FDA-approved Treatment of Peanut Allergy

Peanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.



Xin Xu, MS

Latest:

Factors Associated With Employee Participation in a Value-Based Insurance Design Initiative

We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.


Dawn Sears, MD

Latest:

Evaluation of Dual Versus Triple Therapy for Hepatitis C

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.